Bio - Diagnostics Limited

Bio-Diagnostics Limited, based in Worcester, UK, is a small holding company with an active status, celebrating 45 years in business. Founded in 1979, the company employs 30 people and holds assets valued at £1,651,156. It operates from a real address on the Upton Industrial Estate and is overseen by one director and one owner. The company regularly imports and exports optical and medical tools and devices, with 91 months of import activity and 41 months of export activity recorded.

The company’s website highlights a focus on allergy and autoimmune diagnostics. It offers a range of products and services, including the ALEX allergy testing system, at-home COVID-19 antibody testing, skin prick testing, immunotherapy vaccines, and specialist IHC primary antibodies. It also provides contract manufacturing services and operates a SinuSalt nasal irrigation product line. The website’s design suggests a focus on innovation and customer service, with testimonials from satisfied clients.

Financially, Bio-Diagnostics Limited’s report reveals some concerning trends. Accumulated amortisation for intangible assets has increased by 41%, while depreciation for property, plant, and equipment has risen by 54%. Cash reserves have plummeted by 55%, dropping to £370,000, and net assets have fallen by 34%, reaching £1.4 million. Creditors have increased by 47%, reaching £890,000, and the average number of employees has decreased by 13% to 26. While the company’s turnover is likely below £10.2 million, and its balance sheet total is under £5.1 million, the decline in cash and equity suggests it’s burning through money. The lack of an auditor mentioned is typical for a small company, but the unaudited figures should be viewed with caution. It appears that the company has been working hard, but the financial data indicates a need for careful management.

Registered in England/Wales under the registration number 01464021, with a registered address at WR8 0LX, Worcester, Upton Industrial Estate Rectory Road, Upton-Upon-Severn.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.